News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Shukla Sanjay
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/21/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 336,096 options to buy
@ $2.195, valued at
$737.7k
|
|
02/06/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Exercised 10,375 restricted stock units
@ $0 |
|
11/21/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Bought 10,000 shares
@ $2.1405, valued at
$21.4k
|
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Bought 5,000 shares
@ $6.7613, valued at
$33.8k
|
|
11/15/2021 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Bought 2,500 shares
@ $8.575, valued at
$21.4k
|
|
05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
03/09/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Bought 6,000 shares
@ $4.27, valued at
$25.6k
|
|
05/28/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 80,000 options to buy
@ $4.06, valued at
$324.8k
|
|
02/07/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Sold 745 shares
@ $4.03, valued at
$3k
Granted 39,327 options to buy
@ $4.39, valued at
$172.6k
Exercised 1,786 restricted stock units
@ $0 |
|
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2018 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 300,000 options to buy
@ $3.3, valued at
$990k
|
|
11/03/2017 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 450,000 options to buy
@ $4, valued at
$1.8M
|
|
02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/15/2016 |
4
| Shukla Sanjay (Chief Medical Officer) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 27,500 options to buy
@ $3.06, valued at
$84.2k
|
|
04/01/2016 |
4
| Shukla Sanjay (Chief Medical Officer) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Granted 163,000 options to buy
@ $4.86, valued at
$792.2k
|
|
04/01/2016 |
3
| Shukla Sanjay (Chief Medical Officer) has filed a Form 3 on aTYR PHARMA INC |
|
|